Nuzenio

Yochanra

Yochanra news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 19:24:48 GMTChina approval for TransThera’s Yochanra - The Pharma Letter
Fri, 07 Aug 2026 13:02:10 GMTChina approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord Pharma
Fri, 07 Aug 2026 12:25:36 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical Review
Fri, 07 Aug 2026 11:50:30 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorum
Fri, 07 Aug 2026 06:44:00 GMTYochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China - Yahoo Finance Australia
Fri, 07 Aug 2026 05:38:49 GMTTransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Yochanra.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.